Opiod Use Disorder Clinical Trial
Official title:
Measuring Improvement in the Quality of Emergency Department-initiated Treatment for Opioid Use Disorders Using Observation
This is a multicenter, randomized clinical comparative effectiveness trial (RCT) in which patients with untreated OUD presenting to a Northwell Health Emergency Department (ED), NYULH-Brooklyn, NYULH-Tisch, and Bellevue Hospital will be randomized (1:1) to be managed clinically through either a standard ED visit or an extended visit through ED observation (EDOU).
In this hybrid implementation-effectiveness study, there is no direct research intervention. Rather, clinical care with well-documented effectiveness will be delivered at the discretion of clinical staff guided by clinical protocols for the management of OUD with MOUD (Medications for Opioid Use Disorder) introduced at each site prior to study enrollment. Enrolled patients will be randomized to ED vs. EDOU and to participate in assessments conducted at the index visit and at 30 days and 90 days. Patient level data will also be matched with Medicaid claims data for more robust analyses and to support the development of clinical quality measures. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05304364 -
Safety, Tolerability, and Pharmacokinetics of Naltrexone Implant (DLP-160)
|
Phase 1 | |
| Completed |
NCT03831971 -
The Influence of ANS-6637 on Midazolam Pharmacokinetics in Healthy Volunteers
|
Phase 1 |